Prime

Treatments

Testing and Advancements Index

The Prime Treatments, Testing and Advancements Index is designed to track both event-driven news and long-term trends of companies engaged in developing treatments and vaccines, or diagnostic technology, in the fight against infectious diseases.

FACT SHEET

Prime Treatments, Testing and Advancements Primer

PDF

Infectious Diseases: Prime Treatments, Testing and Advancements Overview

PDF

Prime Treatments, Testing and Advancements Index Methodology Guide

PDF

Prime Treatments, Testing and Advancements Factsheet

PDF

Prime Treatments, Testing and Advancements Index

VIDEO

INDEX KEY FACTS

Base Date: December 12, 2019
Total number of holdings: 67
Launch date: June 08, 2020
Reconstitution: Quarterly (March, June, September and December)
Index calculation agent: Solactive AG
Weighting scheme: Modified Market Capitalization

INDEX SYMBOLS

Version Bloomberg Reuters ISIN
Prime Treatments, Testing and Advancements Index GTR PGERM .PGERMG DE000SL0A030
Prime Treatments, Testing and Advancements Index NTR N/A .PGERMN DE000SL0A022
Prime Treatments, Testing and Advancements Index PR N/A .PGERMP DE000SL0A014

INDEX COMPOSITION

Component Name Ticker Weight Market Cap
ZAI LAB LTD ZLAB 6.24% $15,532,291.43
LABORATORY CRP OF AMER HLDGS LH 6.17% $15,378,560.19
BIO-RAD LABORATORIES INC BIO 5.73% $14,283,337.94
QUEST DIAGNOSTICS INC DGX 5.48% $13,639,348.88
ADAPTIVE BIOTECHNOLOGIES CORP ADPT 4.92% $12,249,887.49
ALNYLAM PHARMACEUTICALS INC ALNY 4.59% $11,429,410.08
BIONTECH SE BNTX 4.59% $11,440,844.18
EMERGENT BIOSOLUTIONS INC EBS 4.35% $10,838,101.28
VIR BIOTECHNOLOGY INC VIR 4.21% $10,473,787.72
MODERNA INC MRNA 4.20% $10,466,646.59
QUIDEL CORP QDEL 3.72% $9,274,411.78
ATEA PHARMACEUTICALS INC AVIR 3.49% $8,690,447.86
CUREVAC BV CVAC 3.47% $8,644,718.87
NOVAVAX INC NVAX 3.41% $8,489,733.97
I-MAB IMAB 2.78% $6,928,056.66
OPKO HEALTH INC OPK 2.27% $5,664,914.89
NANTKWEST INC NK 1.43% $3,571,768.93
DICERNA PHARMACEUTICALS INC DRNA 1.32% $3,290,641.00
TRANSLATE BIO INC TBIO 1.26% $3,136,355.25
INOVIO PHARMACEUTICALS INC INO 1.25% $3,121,665.77
ARCTURUS THERAPEUTICS HOLDINGS INC ARCT 1.25% $3,124,944.07
BIOCRYST PHARMACEUTICALS INC BCRX 1.24% $3,092,871.18
VBI VACCINES INC VBIV 1.21% $3,023,981.33
LUMINEX CORP LMNX 1.01% $2,519,909.46
ALIGOS THERAPEUTICS INC ALGS 1.01% $2,524,850.65
VAXCYTE INC PCVX 0.96% $2,386,701.92
ELI LILLY & CO LLY 0.82% $2,041,035.33
ALEXION PHARMACEUTICALS INC ALXN 0.76% $1,904,269.18
MERIDIAN BIOSCIENCE INC VIVO 0.75% $1,861,892.93
ORASURE TECHNOLOGIES INC OSUR 0.73% $1,808,317.75
ENANTA PHARMACEUTICALS INC ENTA 0.72% $1,800,469.12
GILEAD SCIENCES INC GILD 0.66% $1,632,676.96
JOHNSON & JOHNSON JNJ 0.64% $1,592,698.02
REGENERON PHARMACEUTICALS REGN 0.64% $1,588,698.48
HOLOGIC INC HOLX 0.63% $1,556,821.67
ABBVIE INC ABBV 0.63% $1,571,412.22
BRISTOL-MYERS SQUIBB CO BMY 0.63% $1,567,202.62
ABBOTT LABORATORIES ABT 0.62% $1,534,309.59
GLAXOSMITHKLINE PLC-SPON ADR GSK 0.60% $1,490,870.40
VAXART INC VXRT 0.59% $1,463,065.47
MERCK & CO. INC. MRK 0.59% $1,479,583.27
ASTRAZENECA PLC-SPONS ADR AZN 0.58% $1,446,508.38
SANOFI-ADR SNY 0.58% $1,455,627.79
TAKEDA PHARM-ADR TAK 0.56% $1,395,572.02
PFIZER INC PFE 0.53% $1,330,589.16
SQZ BIOTECHNOLOGIES CO SQZ 0.46% $1,156,135.96
CHIMERIX INC CMRX 0.44% $1,084,086.33
OXFORD IMMUNOTEC GLOBAL PLC OXFD 0.43% $1,075,400.51
CEL-SCI CORP CVM 0.43% $1,061,118.01
DYNAVAX TECHNOLOGIES CORP DVAX 0.43% $1,062,952.37
SIGA TECHNOLOGIES INC SIGA 0.42% $1,050,594.00
CODIAK BIOSCIENCES INC CDAK 0.39% $973,086.60
XBIOTECH INC XBIT 0.36% $908,062.65
CUE BIOPHARMA INC CUE 0.33% $828,290.11
ATHERSYS INC ATHX 0.28% $704,607.29
ARBUTUS BIOPHARMA CORP ABUS 0.27% $661,577.28
CO-DIAGNOSTICS INC CODX 0.26% $637,204.89
HOOKIPA PHARMA INC HOOK 0.24% $608,315.29
PARATEK PHARMACEUTICALS INC PRTK 0.23% $569,333.47
CORMEDIX INC CRMD 0.22% $538,493.40
IBIO INC IBIO 0.20% $500,588.59
IMV INC IMV 0.19% $463,667.08
ASSEMBLY BIOSCIENCES INC ASMB 0.15% $385,631.25
ENOCHIAN BIOSCIENCES INC ENOB 0.12% $293,529.79
ENZO BIOCHEM INC ENZ 0.11% $269,668.86
CONTRAFECT CORP CFRX 0.11% $276,259.53
PHASEBIO PHARMACEUTICALS INC PHAS 0.09% $221,004.76

Prime Treatments, Testing and Advancements Index


CONTACT US

{{message}}